{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:08:38Z","timestamp":1792886918448,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jfma.2023.08.021","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:30:28Z","timestamp":1692898228000},"page":"S82-S90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S2","title":["Who needs to be screened for primary aldosteronism?"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-0131","authenticated-orcid":false,"given":"Wei-Chieh","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-6600","authenticated-orcid":false,"given":"Hao-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0884-9098","authenticated-orcid":false,"given":"Yen-Ta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-5532","authenticated-orcid":false,"given":"Charles","family":"Jia-Yin Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Tah","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-0716","authenticated-orcid":false,"given":"Leay Kiaw","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.08.021_bib1","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"Kayser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2023.08.021_bib3","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2023.08.021_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0029-1243257","article-title":"Comorbidities in primary aldosteronism","volume":"42","author":"Quinkler","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2023.08.021_bib7","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension","volume":"388","author":"Olsen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2023.08.021_bib8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2023.08.021_bib9","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.021_bib10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2023.08.021_bib11","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.021_bib12","first-page":"905","article-title":"[Primary aldosteronism]","volume":"136","author":"Fardella","year":"2008","journal-title":"Rev Med Chile"},{"key":"10.1016\/j.jfma.2023.08.021_bib13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2023.08.021_bib15","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0035-1559645","article-title":"Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan","volume":"47","author":"Sato","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2023.08.021_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jfma.2023.08.021_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jfma.2023.08.021_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jfma.2023.08.021_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.jfma.2023.08.021_bib22","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-17-0946","article-title":"Genetics in endocrinology: the expanding genetic horizon of primary aldosteronism","volume":"178","author":"Monticone","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.021_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","article-title":"Genetics of primary aldosteronism","volume":"22","author":"Mulatero","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.021_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jfma.2023.08.021_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jfma.2023.08.021_bib27","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfma.2023.08.021_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.117.10111","article-title":"Old and new concepts in the molecular pathogenesis of primary aldosteronism","volume":"70","author":"Prada","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/jhh.2017.34","article-title":"Familial hyperaldosteronism type III","volume":"31","author":"Monticone","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1016\/j.jfma.2023.08.021_bib31","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jfma.2023.08.021_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.021_bib33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2023.08.021_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"Clinical practice. The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2023.08.021_bib36","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.021_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.021_bib38","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib39","first-page":"e13","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3093290","article-title":"Baseline demographic and clinical characteristics of patients with adrenal incidentaloma from a single center in China: a survey","volume":"2017","author":"Li","year":"2017","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.021_bib41","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2010-0457","article-title":"Approach to the patient with an adrenal incidentaloma","volume":"95","author":"Nieman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib42","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2023.08.021_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11906-010-0112-8","article-title":"Obstructive sleep apnea and hypertension","volume":"12","author":"Calhoun","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jfma.2023.08.021_bib44","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/HYPERTENSIONAHA.110.154427","article-title":"Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension","volume":"56","author":"Friedman","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/HJH.0000000000000047","article-title":"Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension","volume":"32","author":"Kasai","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.021_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jfma.2023.08.021_bib47","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.021_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.surg.2021.05.052","article-title":"Screening for primary aldosteronism in the hypertensive obstructive sleep apnea population is cost-saving","volume":"171","author":"Chomsky-Higgins Menut","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.jfma.2023.08.021_bib49","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2023.08.021_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jfma.2023.08.021_bib51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/2047487318759853","article-title":"Primary aldosteronism and thyroid disorders in atrial fibrillation: a Swedish nationwide case-control study","volume":"25","author":"Mourtzinis","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jfma.2023.08.021_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.646933","article-title":"New-onset atrial fibrillation in patients with primary aldosteronism receiving different treatment strategies: systematic review and pooled analysis of three studies","volume":"12","author":"Tsai","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfma.2023.08.021_bib53","article-title":"Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism","volume":"24","author":"Sakaguchi","year":"2022","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jfma.2023.08.021_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.021_bib55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/HJH.0000000000002250","article-title":"Atrial fibrillation as presenting sign of primary aldosteronism: results of the prospective appraisal on the prevalence of primary aldosteronism in hypertensive (PAPPHY) study","volume":"38","author":"Seccia","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.021_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15622975.2012.665480","article-title":"Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study","volume":"15","author":"Apostolopoulou","year":"2014","journal-title":"World J Biol Psychiatr"},{"key":"10.1016\/j.jfma.2023.08.021_bib57","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2010-2723","article-title":"Psychological assessment of primary aldosteronism: a controlled study","volume":"96","author":"Sonino","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.021_bib58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000093956","article-title":"Psychological aspects of primary aldosteronism","volume":"75","author":"Sonino","year":"2006","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jfma.2023.08.021_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2021.106187","article-title":"Adrenal adenoma as a cause of atypical psychosis: presentation, diagnosis, surgical technique and outcome (case report with a brief literature review)","volume":"85","author":"Rasras","year":"2021","journal-title":"Int J Surg Case Rep"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623003352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623003352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:51:49Z","timestamp":1760539909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623003352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":59,"alternative-id":["S0929664623003352"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.08.021","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Who needs to be screened for primary aldosteronism?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}